Related Experiment Video
Updated: May 22, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Dose-dense chemotherapy for breast cancer
1Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. sbayraktar@mdanderson.org
The Breast Journal
|May 16, 2012
Summary
Dose-dense chemotherapy, using shorter intervals with growth factor support, shows modest benefits in early-stage breast cancer. Further research is needed to optimize regimens and identify patient subgroups for maximum benefit.
Area of Science:
- Oncology
- Clinical Trials
- Breast Cancer Research
Background:
- Dose-dense chemotherapy aims to maximize effectiveness by aligning treatment with rapid tumor growth.
- Granulocyte-colony stimulating factor (G-CSF) enables safe, shorter chemotherapy intervals.
- Preclinical models suggest this strategy enhances anti-tumor activity.
Purpose of the Study:
- To review the theoretical basis of dose-dense chemotherapy.
- To summarize clinical trial data on dose-dense anthracycline and/or taxane regimens.
- To discuss implications for neoadjuvant and adjuvant breast cancer treatment.
Main Methods:
- Review of randomized clinical trials evaluating dose-dense chemotherapy strategies.
- Analysis of studies using anthracycline and/or taxanes.
- Examination of data from neoadjuvant and adjuvant breast cancer settings.
Main Results:
- Dose-dense strategies demonstrated a modest impact on disease recurrence and overall survival in early-stage breast cancer.
- Subset analyses indicated greater benefits in hormone receptor-negative, highly proliferative, or HER2-overexpressing tumors.
- Feasibility and safety of dose-dense regimens supported by G-CSF were confirmed.
Conclusions:
- Dose-dense chemotherapy offers a modest survival benefit in early-stage breast cancer.
- Specific tumor subtypes may derive greater advantages from this approach.
- Optimal regimens and patient selection require further investigation for personalized treatment.
Related Concept Videos
01:01Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
01:21Dose Size and Dosing Frequency: Determination Methods
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...